AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

21 recruiting trials

for Secondary Hyperparathyroidism

Integrated Diagnosis and Treatment of CKD on Outcomes NCT05242055n/a1 site๐Ÿ“ Beijing Capital Medical University ยท Tests: Integrated diagnosis and treatment for CKD Total Parathyroidectomy With Autotransplantation Versus Total Parathyroidectomy Alone for Secondary Hyperparathyroidism NCT04922892NA1 site๐Ÿ“ Nanjing The Second Hospital of Nanjing Medical University ยท Tests: Parathyroidectomy Pharmacokinetics, Pharmacodynamics, Safety and Tolerability Evaluation of CTAP101 Extended-release Capsules in Pediatric Participants NCT07494045Phase 25 sites๐Ÿ“ Kansas City๐Ÿ“ Columbus๐Ÿ“ Philadelphia OPKO Health, Inc. ยท Tests: CTAP101 The CPH-MBD Cohort Dietary Substudy - Comparison of Methods for Dietary Registrations NCT07312981n/a2 sites๐Ÿ“ Herlev๐Ÿ“ Herlev University of Copenhagen Calcium Isotope Ratios to Assess Calcium Bone Balance in Dialysis Children Receiving Cinacalcet NCT07007338n/a7 sites๐Ÿ“ Bordeaux๐Ÿ“ Bron๐Ÿ“ Montpellier Hospices Civils de Lyon ยท Tests: Supplementary blood samples and urines samples The CPH-MBD Cohort NCT07193056n/a1 site๐Ÿ“ Herlev Herlev Hospital Genetics in the Progression of Nephropathies NCT06416761n/a1 site๐Ÿ“ Milan Ospedale San Raffaele ยท Tests: genetic polymorphisms Assessment of Mineral and Bone Disorders in Kidney Transplant Recipients NCT07141043n/a1 site๐Ÿ“ Iaศ™i Grigore T. Popa University of Medicine and Pharmacy A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis NCT03633708Phase 343 sites๐Ÿ“ Los Angeles๐Ÿ“ Aurora๐Ÿ“ Kansas City Amgen ยท Tests: Etelcalcetide, Standard of Care Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease NCT04522622Phase 44 sites๐Ÿ“ Aalborg๐Ÿ“ Gentofte Municipality๐Ÿ“ Herlev Ditte Hansen ยท Tests: Teriparatide, DXA,VFA, X-ray, HR-pQCT, 18-F NAF PET/CT, Bone biopsy, Cardiac tests, Blood and urine samples and physicaโ€ฆ A Observational Study to Evaluate the Efficacy and Safety of Pacitol Inj. NCT06126016n/a1 site๐Ÿ“ Goyang-si Boryung Pharmaceutical Co., Ltd A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis NCT03969329Phase 323 sites๐Ÿ“ Ghent๐Ÿ“ Prague๐Ÿ“ Bron Amgen ยท Tests: Etelcalcetide Phosphate Assessment in Chronic Kidney Disease Patients Study NCT07368946NA1 site๐Ÿ“ Dallas University of Texas Southwestern Medical Center ยท Tests: Dietary Phosphorus Intake Parathyroid Tumor Clonal Status NCT05997810n/a1 site๐Ÿ“ St Louis Washington University School of Medicine Vitamin D in Dialysis Patients - Diagnostic and Therapeutic Management NCT06571344n/a1 site๐Ÿ“ Gdansk Medical University of Gdansk ยท Tests: Cholecalciferol The Effect of REgulation of PArathyroId hoRmone in Patients With Chronic Kidney Disease to Investigate the Change in Bone Mineral Density NCT07171216NA1 site๐Ÿ“ Herlev Herlev Hospital ยท Tests: Treat to target Activated Charcoal Use in Chronic Kidney Disease Patients NCT06906874Phase 21 site๐Ÿ“ Al Mansurah Mansoura University ยท Tests: Activated Charcoal, Phosphate Binders Study of MT1013 Injection for the Treatment of Secondary Hyperparathyroidism (SHPT) Patients With Chronic Kidney Disease Undergoing Maintenance Dialysis NCT06976177Phase 21 site๐Ÿ“ Hangzhou Shaanxi Micot Pharmaceutical Technology Co., Ltd. ยท Tests: MT1013 Precision Medicine Approaches to Renal Osteodystrophy NCT05880914n/a1 site๐Ÿ“ St Louis Thomas Nickolas ยท Tests: miRNAseq analysis, Standard treatment for bone disorder Diagnosis of Renal Osteodystrophy in Patients With Reduced Renal Function NCT03716128n/a1 site๐Ÿ“ Herlev Ditte Hansen ยท Tests: 18F-PET Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism NCT07122401Phase 31 site๐Ÿ“ Shanghai Shaanxi Micot Pharmaceutical Technology Co., Ltd. ยท Tests: MT1013, Cinacalcet
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy